从事废弃资源综合利用丰倍生物拟于上交所主板IPO上市

Group 1 - The company, Fengbei Biotechnology (603334.SH), plans to issue 35.90 million shares in its initial public offering (IPO), representing 25.02% of the total shares post-issuance, with a total share capital of 143.50 million shares after the IPO [1] - The initial strategic placement will involve 7.18 million shares, accounting for 20.00% of the total issuance, with the pricing inquiry date set for October 22, 2025, and subscription date for October 27, 2025 [1] - The company specializes in the comprehensive utilization of waste resources, primarily focusing on converting waste oils into resource products, forming a production chain from waste oils to biodiesel and bio-based materials [1] Group 2 - The main business of the company revolves around the comprehensive utilization of waste oils, with secondary operations in oil chemical products; key products include bio-based materials and biodiesel [2] - The company's revenue has shown a consistent growth trend over the reporting periods, with total revenues of 1,708.69 million, 1,727.78 million, 1,948.02 million, and 1,478.13 million yuan, while the net profit attributable to the parent company after deducting non-recurring gains and losses was 135.92 million, 123.04 million, 115.32 million, and 84.70 million yuan [2] - The net proceeds from the IPO, after deducting issuance costs, will be invested in projects related to the main business, including the construction of facilities for producing 300,000 tons of methyl oleate, 10,000 tons of industrial-grade mixed oil, and other agricultural microbial agents, totaling an investment of 750 million yuan [2]